Stem cell-based treatment controls blood sugar in people with Type 1 diabetes
An innovative stem cell-based treatment for Type 1 diabetes can meaningfully regulate blood glucose levels and reduce dependence on daily ...
Tag: Diabetes
New drug delivery system could reduce daily diabetes shots to just three a year
Materials engineers at Stanford University have developed a novel hydrogel drug delivery system that transforms daily or weekly injections of ...
Poor nutrition contributes to poor mental health and risk of diabetes
People with diabetes (Diabetes Mellitus) are two-to-three times more likely to have depression than people without, according to the Centers ...
Trend report: High blood pressure increasing in low-income adults; diabetes and obesity on the rise in higher-income adults
Embargoed for release until 5:00 p.m. ET on Monday 20 November 2023 Annals of Internal Medicine Tip Sheet @Annalsofim Below ...
Optimal blood pressure levels for reducing CVD mortality risk identified in large Asian diabetes cohort
SINGAPORE, 17 November 2023 – Keeping blood pressure in check could save lives among Asian adults with type 2 diabetes, ...
UMass Lowell researchers are developing pancreas-like tissue to help people with diabetes
Media contacts: Emily Gowdey-Backus, director of media relations, Emily_GowdeyBackus@uml.edu Nancy Cicco, assistant director of media relations, Nancy_Cicco@uml.edu Credit: UMass Lowell ...
Type 2 diabetes and colorectal cancer risk
About The Study: In this study where the majority of 54,000 participants were African American with low socioeconomic status, diabetes was ...
Semaglutide delivers 20 percent reduction in major adverse cardiovascular events in patients with obesity but no history of diabetes
Semaglutide, the antidiabetic medication that is also used to manage weight, has been shown to deliver a reduction in major ...
International clinical trial finds that semaglutide reduced cardiovascular events by 20% in adults with overweight or obesity who don’t have diabetes
Cleveland: Findings from a multi-center, international clinical trial reported by a Cleveland Clinic physician show that semaglutide reduced cardiovascular events ...
Pennington Biomedical to conduct glycemic control study for patients living with diabetes
Pennington Biomedical researchers, led by Associate Executive Director of Population and Public Health Sciences Dr. Peter Katzmarzyk, with support from ...
Drug screen points toward novel diabetes treatments
A drug currently in clinical trials as a cancer therapy can also stimulate pancreatic beta cells to secrete insulin, revealing ...
Study confirms the use of a new biomarker for predicting non-lymphocytic lesions, including germinoma, in patients with central diabetes insipidus
Central diabetes insipidus (CDI), a rare condition involving the destruction or degeneration of neurons of the hypothalamic-posterior pituitary in the ...
AGA does not endorse all patients stopping popular diabetes and weight loss drugs prior to endoscopy
Bethesda, MD (Nov. 7, 2023) — The American Gastroenterological Association (AGA) has released a rapid clinical practice update addressing the ...
Is high urinary albumin linked to sub-clinical cardiovascular disease in people with type 2 diabetes?
Highlights Imaging tests in individuals with type 2 diabetes without symptoms of cardiovascular disease indicated that elevated albumin in the ...
Sotagliflozin protects kidney and heart in patients with type 2 diabetes and chronic kidney disease
Highlights Results from the phase 3 SCORED trial indicate that sotagliflozin protects kidney and heart health in individuals with type ...
Are sodium-glucose cotransporter-2 inhibitors safe for patients with diabetes and cancer?
Highlights Investigators found that in patients with diabetes and cancer, sodium glucose cotransporter-2 inhibitors were associated with a higher risk ...
Simple automated tool prompts physicians to screen patients with diabetes for kidney disease
Highlights A tool that provides an automated prompt to physicians increased kidney disease screening in patients with type 2 diabetes. ...
Study provides preliminary evidence in favor of a new type 1 diabetes treatment
Type 1 diabetes is an autoimmune disease that causes the body's immune system to attack and destroy insulin-producing beta cells ...
Repurposed drug offers new potential for managing type 1 diabetes
INDIANAPOLIS -- A recent study led by Indiana University School of Medicine in collaboration with the University of Chicago Medicine ...
New research links high salt consumption to risk of Type 2 diabetes
Those at risk for Type 2 diabetes may already know to avoid sugar, but new research suggests they may want ...